Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) produced by myeloma cells is positively correlated with osteolytic markers (such as urinary deoxypyridinoline and serum calcium), indicating that TRAIL may function in osteolysis of MM patients [8]. The gene discussed is TNFSF10; the disease is Miyoshi myopathy.